Sycamore Partners Acquires Walgreens Boots Alliance
Analysis based on 11 articles · First reported Mar 04, 2025 · Last updated Mar 07, 2025
The acquisition of Walgreens Boots Alliance by Sycamore Partners is expected to provide the struggling retailer with the flexibility needed to implement its turnaround strategy away from public market pressures. This could lead to a more stable and potentially profitable Walgreens Boots Alliance in the long term, impacting the retail and healthcare sectors.
Walgreens Boots Alliance has agreed to be acquired by private equity firm Sycamore Partners for an equity value of just under $10 billion, with the total deal value including debt at nearly $24 billion. This move will take Walgreens Boots Alliance private after being a public company since 1927. The company has faced years of financial struggles due to thin prescription reimbursement, rising costs, theft, and inflation-sensitive shoppers. Under CEO Tim Wentworth, Walgreens Boots Alliance has been implementing a turnaround plan, including closing 1,200 U.S. locations, suspending its quarterly dividend, and reducing its stake in Cencora to preserve cash and pay down debt. The company is also reviewing its VillageMD clinic business for potential divestment. The acquisition by Sycamore Partners, known for its investments in retail and consumer brands, aims to give Walgreens Boots Alliance more flexibility to make necessary changes without the immediate scrutiny of Wall Street. This event follows competitor Rite Aid's emergence as a private company from bankruptcy.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard